Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001655759-24-000133
Filing Date
2024-11-12
Accepted
2024-11-12 17:34:03
Documents
1
Period of Report
2023-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1731450837.html 4  
1 FORM 4 wk-form4_1731450837.xml 4 4648
  Complete submission text file 0001655759-24-000133.txt   6309
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Issuer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O 5 SCIENCE PARK 385 WINCHESTER AVENUE NEW HAVEN CT 06511
Business Address
Loomis David K (Reporting) CIK: 0001959410 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38672 | Film No.: 241450109